Tower Research Capital LLC TRC lifted its position in Teleflex Incorporated (NYSE:TFX) by 488.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,259 shares of the medical technology company’s stock after purchasing an additional 1,045 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Teleflex were worth $314,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Toronto Dominion Bank raised its stake in shares of Teleflex by 14.5% in the second quarter. Toronto Dominion Bank now owns 552 shares of the medical technology company’s stock valued at $115,000 after purchasing an additional 70 shares in the last quarter. Cornerstone Capital Management Holdings LLC. acquired a new position in shares of Teleflex in the second quarter valued at $175,000. Coldstream Capital Management Inc. acquired a new position in shares of Teleflex in the third quarter valued at $226,000. Quantitative Systematic Strategies LLC acquired a new position in shares of Teleflex in the fourth quarter valued at $228,000. Finally, Checchi Capital Advisers LLC acquired a new position in shares of Teleflex in the fourth quarter valued at $230,000. Institutional investors and hedge funds own 88.98% of the company’s stock.
Teleflex Incorporated (NYSE TFX) opened at $255.27 on Friday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 3.70 and a current ratio of 2.33. Teleflex Incorporated has a 12 month low of $183.92 and a 12 month high of $288.78. The stock has a market capitalization of $11,237.09, a price-to-earnings ratio of 78.06, a price-to-earnings-growth ratio of 1.84 and a beta of 1.15.
Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 22nd. The medical technology company reported $2.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.40 by $0.04. Teleflex had a return on equity of 16.46% and a net margin of 7.11%. The firm had revenue of $595.10 million during the quarter, compared to analyst estimates of $601.17 million. During the same period in the prior year, the company posted $2.13 earnings per share. The business’s revenue for the quarter was up 15.8% compared to the same quarter last year. equities analysts anticipate that Teleflex Incorporated will post 9.67 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 15th. Shareholders of record on Friday, March 2nd will be paid a dividend of $0.34 per share. The ex-dividend date is Thursday, March 1st. This represents a $1.36 annualized dividend and a yield of 0.53%. Teleflex’s dividend payout ratio is currently 41.59%.
TFX has been the subject of a number of recent research reports. Deutsche Bank lowered Teleflex from a “buy” rating to a “hold” rating and set a $251.00 target price for the company. in a research note on Tuesday, November 14th. Needham & Company LLC upped their target price on Teleflex from $237.00 to $285.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. Jefferies Group upped their target price on Teleflex from $270.00 to $295.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. Piper Jaffray Companies initiated coverage on Teleflex in a research note on Friday, November 10th. They set an “overweight” rating and a $295.00 price objective for the company. Finally, ValuEngine lowered Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the company’s stock. Teleflex has an average rating of “Hold” and a consensus target price of $281.56.
In other news, CEO Benson Smith sold 2,000 shares of the stock in a transaction on Monday, December 4th. The stock was sold at an average price of $258.10, for a total transaction of $516,200.00. Following the sale, the chief executive officer now owns 76,634 shares in the company, valued at $19,779,235.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction on Friday, December 1st. The stock was sold at an average price of $265.32, for a total value of $53,064.00. Following the sale, the director now owns 8,080 shares in the company, valued at approximately $2,143,785.60. The disclosure for this sale can be found here. Insiders have sold 10,100 shares of company stock valued at $2,671,994 over the last quarter. Corporate insiders own 2.39% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Tower Research Capital LLC TRC Purchases 1,045 Shares of Teleflex Incorporated (TFX)” was originally reported by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://transcriptdaily.com/2018/02/25/tower-research-capital-llc-trc-purchases-1045-shares-of-teleflex-incorporated-tfx.html.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.